On Dec. 9, FAP News Today is becoming Amyloidosis News Today
We have some exciting information to share about FAP News Today!
To better serve you and provide even more valuable content, we’re merging FAP News Today with the launch of our newest site, Amyloidosis News Today. This change will be effective Dec. 9.
What this means for you:
- More comprehensive content: You’ll receive a wider range of insightful articles, industry news, and expert tips.
- Consistent delivery: You’ll continue to receive your newsletter weekly, which will be filled with more news, research, and information specific to FAP and other types of amyloidosis.
- Along with this change, we will start to use the updated nomenclature of hereditary transthyretin amyloidosis with polyneuropathy, or hATTR-PN, rather than the older term of familial amyloid polyneuropathy (FAP).
No action required: Simply bookmark amyloidosisnewstoday.com starting Dec. 9. You can continue to receive the latest FAP updates on the new site. If you are subscribed to our newsletter, you don’t need to do anything to continue receiving your weekly updates. Keep an eye on your inbox for the latest issues of Amyloidosis News Today.
We appreciate your continued interest and look forward to providing you with even more valuable content in the future.
Amyloidosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
